National HealthCare Corp. Hits New 52-Week High at $230.29

National HealthCare Corp. has reached a significant milestone by hitting a new 52-week high of USD 230.29 on July 17, 2026. This achievement underscores the company's strong performance in the hospital industry, particularly impressive given its market capitalization of USD 2.5 billion, categorizing it as a small-cap stock. Over the past year, National HealthCare Corp. has demonstrated remarkable growth, with a performance increase of 178.28%, significantly outpacing the S&P 500's 18.43% rise during the same period. The company's price-to-earnings (P/E) ratio stands at 21.00, indicating a solid valuation relative to its earnings. Additionally, the firm boasts a return on equity of 10.96%, reflecting effective management and profitability. With a dividend yield of 1.56% and a price-to-book ratio of 2.34, National HealthCare Corp. continues to show resilience and strength in its financial metrics. The stock's previous 52-week low was recorded at USD 93.54, highlighting the substantial upward movement in its price over the past year.